DANIEL SESSLER
- Type
- Physician · Allopathic & Osteopathic Physicians / Anesthesiology
- Where
- INDEPENDENCE, OH
- NPI
- 1952365835
- Received
- $140,245 in 62 records, 2019 to 2025
- As principal investigator
- $2,101,141 of research payments to others in 56 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 4 | $48,421 |
| 2024 | General payment | 4 | $13,374 |
| 2023 | General payment | 14 | $10,304 |
| 2022 | General payment | 10 | $26,473 |
| 2021 | General payment | 8 | $5,373 |
| 2020 | General payment | 8 | $25,154 |
| 2019 | General payment | 14 | $11,143 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Fresenius Kabi USA, LLC | 3 | $48,360 | 2025 |
| Pacira Pharmaceuticals Incorporated | 11 | $25,252 | 2019–2022 |
| KCI USA, Inc. | 5 | $20,312 | 2021–2023 |
| Edwards Lifesciences Corporation | 20 | $18,554 | 2019–2023 |
| Solventum Corporation | 2 | $8,750 | 2024 |
| Baxter Healthcare | 1 | $4,585 | 2024 |
| AKEBIA THERAPEUTICS INC | 1 | $3,690 | 2022 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,575 | 2023 |
| Merck Sharp & Dohme LLC | 1 | $3,500 | 2021 |
| Masimo Corporation | 8 | $3,192 | 2023–2024 |
| Trevena, Inc. | 4 | $183 | 2021 |
| GE HEALTHCARE | 1 | $99 | 2022 |
| BTG International Inc. | 1 | $64 | 2023 |
| Becton, Dickinson and Company | 1 | $61 | 2025 |
| EAGLE PHARMACEUTICALS, INC. | 1 | $35 | 2023 |
| Philips North America LLC | 1 | $27 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 14 | $95,472 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 8 | $37,027 |
| Education | 2 | $2,896 |
| Travel and Lodging | 6 | $2,842 |
| Food and Beverage | 32 | $2,006 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-19 | Fresenius Kabi USA, LLC | $5,460 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-31 | Fresenius Kabi USA, LLC | $27,300 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-29 | Fresenius Kabi USA, LLC | $15,600 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-14 | Becton, Dickinson and Company | $61 | Food and Beverage | In-kind items and services | 2025 | ||
| 2024-10-28 | Solventum Corporation | $6,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bair Hugger Device, Thermal Regulation Systems & Temp Mgmt Systems | 2024 | |
| 2024-10-22 | Masimo Corporation | $39 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-06-26 | Baxter Healthcare | $4,585 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-06-03 | Solventum Corporation | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bair Paws Device, Thermal Regulation Systems & Temp Mgmt Systems | 2024 | |
| 2023-11-27 | Takeda Pharmaceuticals U.S.A., Inc. | $3,575 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-10-15 | Edwards Lifesciences Corporation | $202 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-10-13 | Masimo Corporation | $10 | Food and Beverage | In-kind items and services | NA Device, CARDIOVASCULAR | 2023 | |
| 2023-06-21 | EAGLE PHARMACEUTICALS, INC. | $35 | Food and Beverage | In-kind items and services | Ryanodex Drug, Hyperthermic Condition | 2023 | |
| 2023-06-03 | Edwards Lifesciences Corporation | $83 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-06-02 | KCI USA, Inc. | $3,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bair Hugger Device, Thermal Regulation Systems & Temp Mgmt Systems | 2023 | |
| 2023-05-25 | BTG International Inc. | $64 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-04-24 | Edwards Lifesciences Corporation | $64 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-04-13 | Masimo Corporation | $2,300 | Education | Cash or cash equivalent | Bridge Device, CARDIOVASCULAR | 2023 | |
| 2023-04-13 | Masimo Corporation | $596 | Education | Cash or cash equivalent | rainbow Acoustic Monitoring Device, CARDIOVASCULAR | 2023 | |
| 2023-02-09 | Masimo Corporation | $76 | Food and Beverage | In-kind items and services | EMMA and ISA Device, CARDIOVASCULAR | 2023 | |
| 2023-01-18 | Masimo Corporation | $125 | Food and Beverage | In-kind items and services | EMMA and ISA Device, CARDIOVASCULAR | 2023 | |
| 2023-01-18 | Masimo Corporation | $22 | Food and Beverage | In-kind items and services | HM 38-02 ASSEMBLY Device, CARDIOVASCULAR | 2023 | |
| 2023-01-18 | Masimo Corporation | $22 | Food and Beverage | In-kind items and services | NA Device, CARDIOVASCULAR | 2023 | |
| 2022-12-22 | AKEBIA THERAPEUTICS INC | $3,690 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-12-21 | Edwards Lifesciences Corporation | $4,777 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | 2022 | ||
| 2022-11-09 | Edwards Lifesciences Corporation | $158 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-23 | Edwards Lifesciences Corporation | $83 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-10-22 | Pacira Pharmaceuticals Incorporated | $37 | Food and Beverage | In-kind items and services | Exparel Drug, Pain Management | 2022 | |
| 2022-09-22 | Edwards Lifesciences Corporation | $752 | Travel and Lodging | Cash or cash equivalent | 2022 | ||
| 2022-09-01 | GE HEALTHCARE | $99 | Food and Beverage | Cash or cash equivalent | 2022 | ||
| 2022-08-08 | KCI USA, Inc. | $5,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bair Hugger Device, Thermal Regulation Systems & Temp Mgmt Systems | 2022 | |
| 2022-06-03 | KCI USA, Inc. | $5,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Bair Hugger Device, Thermal Regulation Systems & Temp Mgmt Systems | 2022 | |
| 2022-05-11 | KCI USA, Inc. | $5,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SpotOn Device, Thermal Regulation Systems & Temp Mgmt Systems | 2022 | |
| 2021-10-21 | Trevena, Inc. | $58 | Food and Beverage | Cash or cash equivalent | OLINVYK Drug, Pain Management | 2021 | |
| 2021-10-21 | Trevena, Inc. | $34 | Food and Beverage | Cash or cash equivalent | OLINVYK Drug, Pain Management | 2021 | |
| 2021-10-21 | Trevena, Inc. | $25 | Food and Beverage | Cash or cash equivalent | OLINVYK Drug, Pain Management | 2021 | |
| 2021-10-16 | Trevena, Inc. | $65 | Food and Beverage | Cash or cash equivalent | OLINVYK Drug, Pain Management | 2021 | |
| 2021-10-09 | Philips North America LLC | $27 | Food and Beverage | Cash or cash equivalent | (6670) MA Undivided Serv Device, Medical Device | 2021 | |
| 2021-08-27 | KCI USA, Inc. | $312 | Consulting Fee | Cash or cash equivalent | ACTIV.A.C. Device, Negative Pressure Systems & Dressings | 2021 | |
| 2021-06-07 | Edwards Lifesciences Corporation | $1,350 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-04-19 | Merck Sharp & Dohme LLC | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2020-12-14 | Pacira Pharmaceuticals Incorporated | $18,000 | Consulting Fee | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-03-06 | Pacira Pharmaceuticals Incorporated | $600 | Consulting Fee | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $6,000 | Consulting Fee | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $462 | Travel and Lodging | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $41 | Food and Beverage | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $32 | Travel and Lodging | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $14 | Food and Beverage | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2020-01-29 | Pacira Pharmaceuticals Incorporated | $3 | Food and Beverage | Cash or cash equivalent | EXPAREL Drug, PAIN MANAGEMENT | 2020 | |
| 2019-11-22 | Edwards Lifesciences Corporation | $2,475 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-10-20 | Edwards Lifesciences Corporation | $140 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-10-19 | Edwards Lifesciences Corporation | $69 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-08-28 | Edwards Lifesciences Corporation | $4,050 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Edwards Lifesciences Corporation | $203 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Edwards Lifesciences Corporation | $47 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-08-21 | Edwards Lifesciences Corporation | $134 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-08-14 | Edwards Lifesciences Corporation | $7 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-07-03 | Edwards Lifesciences Corporation | $1,345 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-06-01 | Edwards Lifesciences Corporation | $107 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-04-24 | Pacira Pharmaceuticals Incorporated | $30 | Food and Beverage | In-kind items and services | EXPAREL Drug, PAIN MANAGEMENT | 2019 | |
| 2019-04-24 | Pacira Pharmaceuticals Incorporated | $30 | Food and Beverage | In-kind items and services | EXPAREL Drug, PAIN MANAGEMENT | 2019 | |
| 2019-04-12 | Edwards Lifesciences Corporation | $2,475 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-02-20 | Edwards Lifesciences Corporation | $26 | Food and Beverage | In-kind items and services | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-10-03 | Masimo Corporation | UNIV OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $47,549 | Continuous Versus Intermittent Ward Monitoring (CONSTANT) (NCT06232876) | 2025 |
| 2025-09-18 | Masimo Corporation | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $1,000 | Sessler/Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious | 2025 |
| 2025-08-21 | Masimo Corporation | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $650 | Sessler/Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious | 2025 |
| 2025-08-21 | Masimo Corporation | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $450 | Sessler/Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious | 2025 |
| 2025-08-21 | Masimo Corporation | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $300 | Sessler/Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious | 2025 |
| 2025-08-21 | Masimo Corporation | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | $4,500 | Sessler/Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious | 2025 |
| 2023-11-15 | GE HEALTHCARE | Cleveland Clinic Hospital | $184,000 | Continuous Ward Monitoring with the GEHC Portrait Mobile Monitoring Solution the COSMOS trial | 2023 |
| 2023-07-14 | Masimo Corporation | Cleveland Clinic Hospital | $32,500 | Continuous Versus Intermittent Ward Monitoring on Vital Sign Abnormalities, Clinical Interventions, and Serious Complica | 2023 |
| 2023-04-18 | Trevena, Inc. | Cleveland Clinic | $71,929 | TRV130 : CP130-4002 Volition Trial | 2023 |
| 2023-03-22 | GE HEALTHCARE | Cleveland Clinic Hospital | $92,000 | Continuous Ward Monitoring with the GEHC Portrait Mobile Monitoring Solution the COSMOS trial | 2023 |
| 2022-12-06 | Masimo Corporation | Cleveland Clinic Hospital | $25,000 | Sessler/Intravenous Oliceridine and opioid-related complications: the VOLITION trial | 2022 |
| 2022-11-16 | Trevena, Inc. | Cleveland Clinic Hospital | $150,021 | TRV130 : CP130-4002 Volition Trial | 2022 |
| 2022-08-24 | Masimo Corporation | Cleveland Clinic Hospital | $1,558 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-08-17 | Masimo Corporation | Cleveland Clinic Hospital | $2,694 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-08-17 | Masimo Corporation | Cleveland Clinic Hospital | $39 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-07-25 | Trevena, Inc. | Cleveland Clinic Hospital | $150,021 | TRV130 : CP130-4002 Volition Trial | 2022 |
| 2022-07-22 | Masimo Corporation | Cleveland Clinic Hospital | $77 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-07-22 | Masimo Corporation | Cleveland Clinic Hospital | $586 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-07-22 | Masimo Corporation | Cleveland Clinic Hospital | $69 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-07-22 | Masimo Corporation | Cleveland Clinic Hospital | $120 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-06-07 | Trevena, Inc. | Cleveland Clinic Hospital | $150,021 | TRV130 : CP130-4002 Volition Trial | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $1,400 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $329 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $329 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $500 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $650 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-05-16 | Masimo Corporation | Cleveland Clinic Hospital | $329 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-04-28 | Masimo Corporation | Cleveland Clinic Hospital | $9,356 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-03-21 | Masimo Corporation | Cleveland Clinic Hospital | $15 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-25 | Masimo Corporation | Cleveland Clinic Hospital | $280 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $3,666 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $1,400 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $131 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $13 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $350 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $1,200 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $97 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $515 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $1,205 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $502 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $128 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $128 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $131 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $128 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-14 | Masimo Corporation | Cleveland Clinic Hospital | $9,356 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-10 | Masimo Corporation | Cleveland Clinic Hospital | $9,356 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-02 | Masimo Corporation | Cleveland Clinic Hospital | $650 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2022-02-02 | Masimo Corporation | Cleveland Clinic Hospital | $329 | Intravenous Oliceridine and Opioid-related Complications: VOLITION: A Multicenter Pilot Cohort Study | 2022 |
| 2021-11-19 | Cardinal Health 200 LLC | Cleveland Clinic Hospital | $23,400 | The Impact Heat Stress Has With and Without Cooling on the Body Temperature and Cognitive Performance of Surgeons Perfor | 2021 |
| 2021-09-16 | Edwards Lifesciences Corporation | Cleveland Clinic Hospital | $40,000 | ASSOCIATION BETWEEN IOH AND AKI AFTER NON-CARDIAC SURGERY IN INFANTS AND CHILDREN | 2021 |
| 2021-07-09 | Cardinal Health 200 LLC | Cleveland Clinic Hospital | $46,800 | The Impact Heat Stress Has With and Without Cooling on the Body Temperature and Cognitive Performance of Surgeons Perfor | 2021 |
| 2020-10-15 | Cardinal Health 200 LLC | Cleveland Clinic | $46,800 | The Impact Heat Stress Has With and Without Cooling on the Body Temperature and Cognitive Performance of Surgeons Perfor | 2020 |
| 2020-09-10 | Cardinal Health 200 LLC | Cleveland Clinic | $39,000 | The Impact Heat Stress Has With and Without Cooling on the Body Temperature and Cognitive Performance of Surgeons Perfor | 2020 |
| 2020-08-01 | KCI USA, Inc. | Cleveland Clinic Hospital | $441,309 | Mild Perioperative Hypothermia and Major Adverse Cardiovascular Outcomes/Troponin - Cleveland Clinic | 2020 |
| 2019-04-03 | 3M Company | CLEVELAND CLINIC HOSPITAL | $433,573 | Mild Perioperative Hypothermia and Major Adverse Cardiovascular Outcomes/Troponin - Cleveland Clinic | 2019 |
| 2019-03-06 | 3M Company | CLEVELAND CLINIC HOSPITAL | $72,691 | Comparison of temperature measurement of a comparison device and 3M Bair Hugger Temperature Monitoring System | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Independence, OH, county Cuyahoga County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Independence, OH | County Cuyahoga County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 7,534 | 1,245,873 | 11,810,293 |
| Population, 2020 census P1 | 7,584 | 1,264,817 | 11,799,448 |
| Median age B01002 | 48.4 | 40.4 | 39.7 |
| Under 18 B01001 | 19.2% | 20.5% | 22.0% |
| 65 and over B01001 | 25.5% | 19.5% | 18.3% |
| Households B11001 | 3,121 | 554,551 | 4,863,191 |
| Foreign born B05002 | 3.1% | 7.7% | 5.2% |
| Median household income B19013 | $115,733 | $64,468 | $71,389 |
| Median family income B19113 | $126,413 | $89,252 | $92,749 |
| Per capita income B19301 | $58,711 | $42,747 | $40,552 |
| Poverty rate B17001 | 2.4% | 16.1% | 13.3% |
| Unemployment rate B23025 | 1.5% | 6.6% | 4.8% |
| Civilian labor force B23025 | 4,068 | 650,577 | 5,994,779 |
| Mean commute (minutes) B08013 | 22.6 | 23.3 | 23.4 |
| Bachelor's degree or higher B15003 | 47.4% | 36.5% | 31.5% |
| Housing units B25001 | 3,217 | 615,331 | 5,292,391 |
| Owner-occupied B25003 | 90.4% | 59.4% | 67.2% |
| Renters B25003 | 9.6% | 40.6% | 32.8% |
| Median home value B25077 | $309,900 | $195,400 | $214,800 |
| Median gross rent B25064 | $1,383 | $1,060 | $1,034 |
| White, not Hispanic B03002 | 92.4% | 56.5% | 75.8% |
| Black B03002 | 1.8% | 28.5% | 12.0% |
| Hispanic or Latino B03002 | 1.3% | 7.0% | 4.8% |
| Asian B03002 | 1.4% | 3.3% | 2.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Independence, OH.
Comments